Provectus Biopharmaceuticals Inc. Retains PharmaHEALTHLabs To Facilitate Investigator Advisory Board Meeting During 11Th Brazilian Melanoma Conference

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT,, a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”), announced that it has retained healthcare communications company PharmaHEALTHLabs to coordinate and facilitate an Investigator Advisory Board meeting to be held during 11th Brazilian Melanoma Conference from August 13-15, 2015 in Goiania, Brazil.

Help employers find you! Check out all the jobs and post your resume.

Back to news